Friday, July 31, 2026

Lenovo’s Legion 9i Delivers 280W Gaming Power and Immersive 3D Display

Lenovo's Legion 9i gaming laptop features a 4K display, 3D capabilities, AI integration, and impressive hardware specifications for gamers.

Seoul Welcomes Lula in Symbolic Show of Democratic Unity

President Lee Jae Myung welcomes Brazilian President Lula, highlighting their shared journeys and anticipating a fruitful summit.

UNIST startup goes public on KOSDAQ with precision cooling medical devices

RecensMedical, a UNIST startup, goes public on KOSDAQ, advancing precision cooling tech for medical applications and global expansion.

Tag: biotechnology

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Unlocking the Future of Cancer Treatment: UCI-101 CAR-NK Therapy by UCI Therapeutics

Matica BioLabs partners with UC Therapeutics to manufacture CAR-NK cell therapy, enhancing cancer treatment through dual-targeting technology.

AI in Healthcare: How Lunit and KAIST Are Revolutionizing Medical Technology in 2026

South Korea enhances AI in healthcare with Lunit and KAIST's models, achieving high accuracy and speed for medical applications.

ABL Bio to Invest Additional $25 Million in Neok Bio to Accelerate ADC Clinical Trials

ABL Bio invests $25M in Neok Bio for bispecific antibody-drug conjugate trials, aiming for FDA-approved treatments by 2027.

GC Cell’s CAR-NK: Revolutionizing Solid Tumor Treatment with New Patent

GC Cell has patented an immunotherapy targeting solid tumors using its CAR-NK platform, aiming for safer, cost-effective treatments.

Matica Biotechnologies Signs Adenovirus Therapy CDMO Deal With North American Research Institution

CHA Biotech's U.S. subsidiary, Matica Biotechnologies, secures a CDMO agreement for adenovirus therapy with a major North American institution.

NovaCell Technology Passes KOSDAQ Evaluation: What This Means for DongKoo BioPharm’s Future

Donggu Bio Pharmaceutical announces that its invested company, Novacell Technologies, has passed the technical evaluation for KOSDAQ listing.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

Curiosis: Revolutionizing Bio Research with Automated Cell Imaging Systems

Curiosis enhances biomedical research with automated cell analysis, aiming for profitability and becoming a leading lab automation provider.

HLB BioStep Signs Strategic MOU with CLIPS BnC… Toward Integrated Preclinical and Clinical Development

HLB BioStep and CLIPS BnC sign MOU to enhance collaboration between preclinical and clinical stages of drug development.

GCCell Secures Groundbreaking Patent for Next-Gen Cell Therapy: What It Means for the Future of Immunotherapy

GC Cell has completed the registration of core technology patents for next-gen cell and gene therapies in South Korea and Japan.

Can AI Speed Up Drug R&D?: PharmGen Science Teams With Polaris AI Pharma Across the Full Development Cycle

PharmGen Science partners with Polaris AI Pharma to enhance drug development using AI technologies and optimize R&D processes.

Column-Free Antibody Purification Breakthrough: 97%+ Purity, 4x Faster, and 12x Fewer Impurities

KICET introduces a cost-effective antibody purification system using Tangential Flow Filtration, enhancing efficiency and purity in drug production.

Unlocking the Future of Healthcare: How Adaptive Clinical Trials Can Transform Regenerative Medicine in Asia

The article discusses South Korea's efforts to ease regulations on regenerative medicine to improve patient access while addressing significant challenges.

Unlocking the Future: How Neuracle Science’s NS101 is Set to Revolutionize Alzheimer’s Treatment by 2030

Neuracle Science aims for a KOSDAQ listing and focuses on developing NS101 for neurological diseases, attracting global interest.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.